<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:department>College of Life Sciences</gtr:department><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/90051600-6EF2-4093-BA8C-2B4B6F550895"><gtr:id>90051600-6EF2-4093-BA8C-2B4B6F550895</gtr:id><gtr:name>University of Dundee</gtr:name><gtr:address><gtr:line1>University of Dundee</gtr:line1><gtr:line2>Nethergate</gtr:line2><gtr:postCode>DD1 4HN</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/34A3A2B9-9F8D-4704-9DDC-534A423EF333"><gtr:id>34A3A2B9-9F8D-4704-9DDC-534A423EF333</gtr:id><gtr:firstName>Tricia</gtr:firstName><gtr:surname>Cohen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0901221"><gtr:id>F0B7B8E6-EBDB-4497-BCE1-0802DC6F87CC</gtr:id><gtr:title>Roles of a serine/threonine-specific phosphatase in steroid receptor function</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0901221</gtr:grantReference><gtr:abstractText>Glucocorticoids are widely used for the treatment of inflammatory and autoimmune diseases, but their use is limited by side effects, which include fat deposits and impaired use of blood sugar. The protein within tissues, which binds the glucocorticoids is the glucocorticoid receptor, but its interactions with other proteins and how the glucocortcoid receptor complexes regulate cell function are incompletely understood. My recent research has shown that a protein phosphatase, called Ppp5, which removes phosphate from proteins, may be crucial for the normal function of the glucocorticoid receptor in vivo. The aims of this project are to employ tissues from a mouse model that I have made in which Ppp5 does not work. This new mouse line provides an important and unique opportunity to understand how Ppp5 controls the body's response to glucocorticoids.</gtr:abstractText><gtr:technicalSummary>Abstract of Research 
Glucocorticoids are widely used to treat inflammatory and autoimmune disorders, but their use is limited by side effects, which include metabolic derangements such as central adiposity, glucose intolerance and insulin resistance. Glucocorticoids bind to the glucocorticoid receptor (GR), their mechanisms of action and cell-type specific signalling are only partially understood. GR complexes are thought to comprise a receptor polypeptide, heat shock protein (Hsp) 90 and one of four tetratricopeptide repeat (TPR) proteins that include protein phosphatase, Ppp5. The latter is the only phosphatase encoded by the human genome that contains a TPR domain. Other laboratories have reported that Ppp5 interacts with the GR and, based on overexpression and RNA knockdown studies, they have reported that Ppp5 modulates GR function. I have recently developed a mouse line in which wild type Ppp5 is replaced by a catalytically inactive mutant, Ppp5KI, and the aim of the project to exploit this new powerful knock-in model to establish the role that Ppp5 plays in regulating GR function in vivo in order to ascertain whether modulating Ppp5 activity by a pharmaceutical may be useful.</gtr:technicalSummary><gtr:fund><gtr:end>2013-07-25</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-07-26</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>325572</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Dundee</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Biological Chemistry and Drug Discovery (BCDD)</gtr:department><gtr:description>Assessment of mouse phenotype by magnetic resonance imaging</gtr:description><gtr:id>D5555C01-083D-4987-B17E-BD3992346FC4</gtr:id><gtr:impact>The studies supported biochemical analysis of the mouse phenotype.</gtr:impact><gtr:outcomeId>CNiW6dxkmus-1</gtr:outcomeId><gtr:partnerContribution>Collaborator provided the experimental procedure and expertise for analysis of the mouse model by magnetic resonance imaging.</gtr:partnerContribution><gtr:piContribution>The mouse model was provided by my research and my postdoctoral research assistant performed the experiments and analysis of the data under guidance from the collaborator.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Mouse model in which the gene expressing the protein phosphatase Ppp5 is replaced by a gene expressing Ppp5 in which aspartic acid 274 is replaced by alanine. Ppp5Asp274Ala is essentially inactive (expressing &amp;lt;0.3 % of the wild type enzyme activity).</gtr:description><gtr:id>E0023046-1B50-4911-B23C-E97D662E35C9</gtr:id><gtr:impact>The Ppp5KI mouse model exhibits decreased weight gain compared with controls, alteration of glucocorticoid receptor function and decreased abdominal adipose tissue.</gtr:impact><gtr:outcomeId>VqUNVAgq3cB</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Mouse model (Ppp5KI)</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2014</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Antibodies have been raised, which recognize mouse protein phosphatase 5 (Ppp5/PP5).</gtr:description><gtr:id>6FD2D41D-E373-495F-A62B-4A6E5A920472</gtr:id><gtr:impact>The antibodies enable the expression levels and interactions of Ppp5 in the transgenic mouse to be ascertained.</gtr:impact><gtr:outcomeId>VXqktbuzdVg</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Antibodies</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>256F8AFA-5A7F-4856-B74F-CF565F45A1F6</gtr:id><gtr:title>Decreased adipogenesis and adipose tissue in mice with inactivated protein phosphatase 5.</gtr:title><gtr:parentPublicationTitle>The Biochemical journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c97387b5987e1d0794e5fbc7887a8f64"><gtr:id>c97387b5987e1d0794e5fbc7887a8f64</gtr:id><gtr:otherNames>Jacob W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0264-6021</gtr:issn><gtr:outcomeId>doi_55f9859852d228fe</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0901221</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>